IFF's Designed Enzymatic Biomaterials™ Platform Debuts in Large-Scale Home Care Application

IFF
September 18, 2025
IFF announced the first large-scale commercial use of its Designed Enzymatic Biomaterials™ (DEB) platform, with a major consumer packaged goods company launching a new laundry detergent formulation enhanced by DEB technology. This formulation delivers improved fabric softness and cleaning performance. The DEB technology replaces non-biodegradable ingredients with a readily biodegradable alternative, aligning with growing demand for sustainable solutions. Leticia Gonçalves, president of Health & Biosciences at IFF, stated that DEB has the power to redefine biochemical materials by being tailored, functional, nature-inspired, and safer. The Lyrature™ portfolio, featuring DEB-based products, will replace persistent, non-biodegradable ingredients like polyquaterniums in laundry formulations, offering bio-based solutions for surface modification and anti-redeposition benefits. IFF is further scaling DEB through its Alpha Bio joint venture with Kemira, with a dedicated manufacturing asset expected to start production in 2027. The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.